Lenabasum, a cannabinoid type 2 receptor agonist, exerts anti-inflammatory effects in dermatomyositis
Fields of Study & Subjects
Cannabis and Cannabinoid Research
Forensic Toxicology and Drug Analysis
Psoriasis: Treatment and Pathogenesis
Publication details
- Journal / source
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Volume
- 146
- Issue
- 7
- Pages
- 1827–1836.e4
- Publication date
- 15 January 2026
- Language
- EN